These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12520120)

  • 1. Novel method to control release of lipophilic drugs with high potency from silicone.
    Kajihara M; Sugie T; Sano A; Fujioka K; Urabe Y; Tanihara M; Imanishi Y
    Chem Pharm Bull (Tokyo); 2003 Jan; 51(1):11-4. PubMed ID: 12520120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel drug delivery device using silicone: controlled release of insoluble drugs or two kinds of water-soluble drugs.
    Kajihara M; Sugie T; Maeda H; Sano A; Fujioka K; Urabe Y; Tanihara M; Imanishi Y
    Chem Pharm Bull (Tokyo); 2003 Jan; 51(1):15-9. PubMed ID: 12520121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solutions for lipophilic drugs: a biodegradable polymer acting as solvent, matrix, and carrier to solve drug delivery issues.
    Asmus LR; Gurny R; Möller M
    Int J Artif Organs; 2011 Feb; 34(2):238-42. PubMed ID: 21374569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the release behavior of a covered-rod-type formulation using silicone.
    Maeda H; Ohashi E; Sano A; Kawasaki H; Kurosaki Y
    J Control Release; 2003 Jun; 90(1):59-70. PubMed ID: 12767707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to adjust dexamethasone mobility in silicone matrices: A quantitative treatment.
    Gehrke M; Sircoglou J; Vincent C; Siepmann J; Siepmann F
    Eur J Pharm Biopharm; 2016 Mar; 100():27-37. PubMed ID: 26686648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on accelerated evaluation system for release profiles of covered-rod type silicone formulation using indomethacin as a model drug.
    Maeda H; Sugie T; Sano A; Kawasaki H; Kurosaki Y
    J Control Release; 2004 Feb; 94(2-3):337-49. PubMed ID: 14744485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics.
    Chorny M; Fishbein I; Danenberg HD; Golomb G
    J Control Release; 2002 Oct; 83(3):389-400. PubMed ID: 12387947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing the Alba
    Chillon A; Pace A; Zuccato D
    PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K; Sistla R; Shastri NR
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of beta-estradiol from biodegradable microparticles within a silicone matrix.
    Brannon-Peppas L
    J Biomater Sci Polym Ed; 1994; 5(4):339-51. PubMed ID: 8025030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in silicones for topical and transdermal drug delivery.
    Aliyar H; Schalau G
    Ther Deliv; 2015 Jul; 6(7):827-39. PubMed ID: 26228774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of wettability and surface activity on release behavior of hydrophilic substances from lipid matrices.
    Koennings S; Berié A; Tessmar J; Blunk T; Goepferich A
    J Control Release; 2007 Jun; 119(2):173-81. PubMed ID: 17412444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a new drug delivery system for protein drugs using silicone (II).
    Kajihara M; Sugie T; Hojo T; Maeda H; Sano A; Fujioka K; Sugawara S; Urabe Y
    J Control Release; 2001 Jun; 73(2-3):279-91. PubMed ID: 11516505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of nanostructured lipid carriers for the encapsulation and controlled release of vitamin D3.
    Park SJ; Garcia CV; Shin GH; Kim JT
    Food Chem; 2017 Jun; 225():213-219. PubMed ID: 28193417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
    Gaba B; Fazil M; Ali A; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2015; 22(6):691-700. PubMed ID: 24670099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using a drug to structure its release matrix and release profile.
    Brook MA; Holloway AC; Ng KK; Hrynyk M; Moore C; Lall R
    Int J Pharm; 2008 Jun; 358(1-2):121-7. PubMed ID: 18407444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron(II) sulfate release from drop-formed lipophilic matrices developed by special hot-melt technology.
    Pallagi E; Vass K; Pintye-Hódi K; Kása P; Falkay G; Eros I; Szabó-Révész P
    Eur J Pharm Biopharm; 2004 Mar; 57(2):287-94. PubMed ID: 15018986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of additives and processing parameters on the initial burst release of protein from poly(lactic-co-glycolic acid) microspheres.
    Zheng CH; Gao JQ; Liang WQ; Yu HY; Zhang YL
    PDA J Pharm Sci Technol; 2006; 60(1):54-9. PubMed ID: 17089678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach.
    Patil H; Feng X; Ye X; Majumdar S; Repka MA
    AAPS J; 2015 Jan; 17(1):194-205. PubMed ID: 25344439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled dual drug release by coaxial electrospun fibers - Impact of the core fluid on drug encapsulation and release.
    Wang J; Windbergs M
    Int J Pharm; 2019 Feb; 556():363-371. PubMed ID: 30572080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.